Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Journal of Anesthesia, Analgesia and Critical Care

Fig. 5

From: Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study

Fig. 5

Clinical parameters between groups and over the course of time. a 30 days trend mean CRP (mg/l) grouped by NRBC cut-off value ≥ 500/µl, n = 413. b 30 days trend mean leukocytes (GPt/l) grouped by NRBC cut-off value ≥ 500/µl, n = 410. c 30 days trend mean Bilirubin (µmol/l) grouped by NRBC cut-off value ≥ 500/µl, n = 408. d 30 days trend mean PCT (ng/ml) grouped by NRBC cut-off value ≥ 500/µl, n = 411. e 30 days trend mean PEEP (cmH2O) grouped by NRBC cut-off value ≥ 500/µl, n = 412. f 30 days trend Pmean (cmH2O) grouped by NRBC cut-off value ≥ 500/µl, n = 412. Data are presented as mean ± standard deviation (SD)

Back to article page